This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Nobuyuki Itoh: Innovator in Hepatocyte-Specific Growth Factors
Introduction
Nobuyuki Itoh is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of hepatocyte growth factors. His work has implications for various medical applications, including liver-related therapies.
Latest Patents
Nobuyuki Itoh holds a patent for "Polynucleotides encoding hepatocyte-specific members of the FGF family." This patent describes nucleic acid molecules that are useful in vectors, transformed or transfected host cells, and methods for the recombinant expression of hepatocyte growth-specific polypeptide members of the FGF family. This innovation is crucial for advancing research in liver health and disease.
Career Highlights
Itoh is associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Tsutomu Arakawa and Dimitry Michael Danilenko. Their combined expertise has fostered a collaborative environment that enhances the development of new biotechnological solutions.
Conclusion
Nobuyuki Itoh's contributions to the field of hepatocyte growth factors exemplify the impact of innovative research in biotechnology. His patent and collaborations highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
